Invention Grant
- Patent Title: Antagonists targeting the TGF-β pathway
-
Application No.: US16706187Application Date: 2019-12-06
-
Publication No.: US10851157B2Publication Date: 2020-12-01
- Inventor: Margaret Karow , Jackie Sheng , Wei Zhang
- Applicant: GENSUN BIOPHARMA, INC.
- Applicant Address: US CA Newbury Park
- Assignee: Gensun Biopharma, Inc.
- Current Assignee: Gensun Biopharma, Inc.
- Current Assignee Address: US CA Newbury Park
- Agency: Morris, Manning & Martin, LLP
- Agent Michael X. Ye
- Main IPC: C07K16/22
- IPC: C07K16/22 ; C07K16/28
Abstract:
Antitumor antagonists that bind specifically to immune checkpoint regulators, angiogenesis pathway regulators and/or TGF pathway regulators are disclosed. Also disclosed are methods for treating proliferative disorders, infections, and immunological disorders with the antitumor antagonists described herein.
Public/Granted literature
- US20200231665A1 ANTAGONISTS TARGETING THE TGF-B PATHWAY Public/Granted day:2020-07-23
Information query
